Financing, Equity Capital Markets

Praxis Precision Medicines, Inc.

03/24
|
$200.0 Million
Praxis Precision Medicines
Piper Sandler served as bookrunner for Praxis Precision Medicines, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma